AU2009212645B2 - 3,8-diaminotetrahydroquinoline derivative - Google Patents
3,8-diaminotetrahydroquinoline derivative Download PDFInfo
- Publication number
- AU2009212645B2 AU2009212645B2 AU2009212645A AU2009212645A AU2009212645B2 AU 2009212645 B2 AU2009212645 B2 AU 2009212645B2 AU 2009212645 A AU2009212645 A AU 2009212645A AU 2009212645 A AU2009212645 A AU 2009212645A AU 2009212645 B2 AU2009212645 B2 AU 2009212645B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- compound
- ohz
- oxo
- tetrahydroquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008-029781 | 2008-02-08 | ||
JP2008029781 | 2008-02-08 | ||
JP2008277044 | 2008-10-28 | ||
JP2008-277044 | 2008-10-28 | ||
PCT/JP2009/000487 WO2009098901A1 (ja) | 2008-02-08 | 2009-02-06 | 3,8-ジアミノテトラヒドロキノリン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2009212645A1 AU2009212645A1 (en) | 2009-08-13 |
AU2009212645B2 true AU2009212645B2 (en) | 2012-07-19 |
Family
ID=40951980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2009212645A Ceased AU2009212645B2 (en) | 2008-02-08 | 2009-02-06 | 3,8-diaminotetrahydroquinoline derivative |
Country Status (20)
Country | Link |
---|---|
US (2) | US8299255B2 (ja) |
EP (1) | EP2241564B1 (ja) |
JP (1) | JP5493870B2 (ja) |
KR (1) | KR101553725B1 (ja) |
CN (1) | CN101939313B (ja) |
AU (1) | AU2009212645B2 (ja) |
BR (1) | BRPI0907749A2 (ja) |
CA (1) | CA2714480C (ja) |
CY (1) | CY1115138T1 (ja) |
DK (1) | DK2241564T3 (ja) |
ES (1) | ES2464342T3 (ja) |
HR (1) | HRP20140449T1 (ja) |
MX (1) | MX2010008740A (ja) |
PL (1) | PL2241564T3 (ja) |
PT (1) | PT2241564E (ja) |
RU (1) | RU2482117C2 (ja) |
SI (1) | SI2241564T1 (ja) |
TW (1) | TWI422585B (ja) |
WO (1) | WO2009098901A1 (ja) |
ZA (1) | ZA201005346B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103328449A (zh) * | 2011-01-26 | 2013-09-25 | 霍夫曼-拉罗奇有限公司 | 新的四氢喹啉衍生物 |
TWI662967B (zh) | 2013-03-25 | 2019-06-21 | 日商志瑞亞新藥工業股份有限公司 | 食後期之胃運動亢進劑 |
CN104193722A (zh) * | 2014-08-27 | 2014-12-10 | 湖南华腾制药有限公司 | 一种n-叔丁氧羰基-3-甲胺噻吩的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
JP3817746B2 (ja) | 1994-06-20 | 2006-09-06 | 株式会社竹屋 | パチンコ島台 |
CA2301566A1 (en) | 1997-08-22 | 1999-03-04 | Kaken Pharmaceutical Co., Ltd. | N-acylated lipophilic amino acid derivatives |
US6211174B1 (en) * | 1997-10-31 | 2001-04-03 | Merck & Co., Inc. | Naphtho-fused lactams promote release of growth hormone |
UA73530C2 (uk) | 1999-11-10 | 2005-08-15 | Ново Нордіск А/С | Сполука з властивостями вивільнювати гормон росту |
RU2277092C2 (ru) * | 2000-09-15 | 2006-05-27 | Анормед, Инк. | Гетероциклические соединения, их применение и фармацевтическая композиция для лечения состояний, опосредованных схсr4 и ccr5 |
WO2005007628A1 (en) * | 2003-07-11 | 2005-01-27 | Bristol-Myers Squibb Company | Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
WO2008116107A2 (en) | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
-
2009
- 2009-02-06 RU RU2010137336/04A patent/RU2482117C2/ru not_active IP Right Cessation
- 2009-02-06 SI SI200930930T patent/SI2241564T1/sl unknown
- 2009-02-06 MX MX2010008740A patent/MX2010008740A/es active IP Right Grant
- 2009-02-06 BR BRPI0907749-9A patent/BRPI0907749A2/pt not_active Application Discontinuation
- 2009-02-06 ES ES09707360.5T patent/ES2464342T3/es active Active
- 2009-02-06 KR KR1020107016651A patent/KR101553725B1/ko active IP Right Grant
- 2009-02-06 EP EP09707360.5A patent/EP2241564B1/en active Active
- 2009-02-06 CN CN2009801045187A patent/CN101939313B/zh not_active Expired - Fee Related
- 2009-02-06 PL PL09707360T patent/PL2241564T3/pl unknown
- 2009-02-06 WO PCT/JP2009/000487 patent/WO2009098901A1/ja active Application Filing
- 2009-02-06 JP JP2009552416A patent/JP5493870B2/ja active Active
- 2009-02-06 US US12/866,843 patent/US8299255B2/en active Active
- 2009-02-06 AU AU2009212645A patent/AU2009212645B2/en not_active Ceased
- 2009-02-06 CA CA2714480A patent/CA2714480C/en not_active Expired - Fee Related
- 2009-02-06 DK DK09707360.5T patent/DK2241564T3/da active
- 2009-02-06 PT PT97073605T patent/PT2241564E/pt unknown
- 2009-02-06 TW TW098103925A patent/TWI422585B/zh not_active IP Right Cessation
-
2010
- 2010-07-27 ZA ZA2010/05346A patent/ZA201005346B/en unknown
-
2012
- 2012-09-14 US US13/617,469 patent/US8501772B2/en active Active
-
2014
- 2014-05-20 HR HRP20140449AT patent/HRP20140449T1/hr unknown
- 2014-06-03 CY CY20141100391T patent/CY1115138T1/el unknown
Non-Patent Citations (1)
Title |
---|
ROSAUER, K.G. et al., Bioorg. Med. Chem. Lett., 2003, vol. 13, pages 4385-4388. * |
Also Published As
Publication number | Publication date |
---|---|
TWI422585B (zh) | 2014-01-11 |
CA2714480A1 (en) | 2009-08-13 |
JP5493870B2 (ja) | 2014-05-14 |
US8299255B2 (en) | 2012-10-30 |
WO2009098901A1 (ja) | 2009-08-13 |
JPWO2009098901A1 (ja) | 2011-05-26 |
MX2010008740A (es) | 2010-08-30 |
CA2714480C (en) | 2017-03-28 |
CN101939313B (zh) | 2013-05-22 |
DK2241564T3 (da) | 2014-05-19 |
RU2482117C2 (ru) | 2013-05-20 |
ZA201005346B (en) | 2011-11-30 |
RU2010137336A (ru) | 2012-03-20 |
US8501772B2 (en) | 2013-08-06 |
TW200940530A (en) | 2009-10-01 |
BRPI0907749A2 (pt) | 2015-07-21 |
PL2241564T3 (pl) | 2014-09-30 |
KR20100116175A (ko) | 2010-10-29 |
KR101553725B1 (ko) | 2015-09-16 |
CY1115138T1 (el) | 2016-12-14 |
US20130012537A1 (en) | 2013-01-10 |
EP2241564A4 (en) | 2011-07-20 |
SI2241564T1 (sl) | 2014-06-30 |
HRP20140449T1 (hr) | 2014-06-20 |
US20100317693A1 (en) | 2010-12-16 |
ES2464342T3 (es) | 2014-06-02 |
CN101939313A (zh) | 2011-01-05 |
EP2241564B1 (en) | 2014-04-30 |
EP2241564A1 (en) | 2010-10-20 |
PT2241564E (pt) | 2014-06-12 |
AU2009212645A1 (en) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5125501B2 (ja) | 1,3−ジヒドロ−2h−インドール−2−オン化合物、及び芳香族複素環が縮合したピロリジン−2−オン化合物 | |
AU691201B2 (en) | Endothelin receptor antagonists | |
US5804578A (en) | Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone | |
JPH10510511A (ja) | 成長ホルモンの放出を促進するジペプチド類 | |
EP0336356A2 (en) | Derivatives of tryptophan as CCK antagonists | |
EP2729443A1 (en) | Benzylamine derivatives as inhibitors of plasma kallikrein | |
US5877182A (en) | Piperidines promote release of growth hormone | |
KR100820598B1 (ko) | 트리펩티딜 펩티다아제 저해제 | |
KR20100017547A (ko) | 신규 시클릭 펩티드 화합물 | |
IE902238A1 (en) | Tetrapeptide type-b cck receptor ligands | |
US5965565A (en) | Piperidines promote release of growth hormone | |
AU2009212645B2 (en) | 3,8-diaminotetrahydroquinoline derivative | |
US5817654A (en) | N-substituted naphthofused lactams | |
WO1990006937A1 (en) | Derivatives of tetrapeptides as cck agonists | |
PT94562A (pt) | Processo de preparacao de ligandos dos receptores cck do tipo b,tetrapeptidicose de composicoes farmaceuticas que os contem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |